Monograph Title | Section | Source Publication | Page Number Sort descending | Errata Post Date | Errata Official Date | Target Errata Print Publication | Target Online Fix Publication | Description |
---|---|---|---|---|---|---|---|---|
BLACK CUMIN SEED THYMOQUINONE OIL | DEFINITION | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | Change carvacol to: carvacrol |
AMOXICILLIN BOLUSES | IDENTIFICATION | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | Change Application volume, Developing solvent system, Procedure—Proceed as directed for the Identification test under Amoxicillin Tablets. to: Application volume—5 µL. Developing solvent system… Read More |
IPRATROPIUM BROMIDE INHALATION SOLUTION | IMPURITIES | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Organic Impurities: Change Column: 4.6-mm × 25-µm; 5-µm packing L1 to: Column: 4.6-mm × 25-cm; 5-µm packing L1 |
DOXYCYCLINE HYCLATE | CHEMICAL INFORMATION | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | Change 1025.87 to: 1025.88 |
LATANOPROST | ASSAY/Procedure | USPNF Online | Online | 29-Jul-2022 | 1-Dec-2022 | NA | NA | Change Standard solution: Transfer 2.0 mg/mL of USP Latanoprost RS into a suitable volumetric flask, dissolve in dehydrated alcohol equivalent to 20% of the final volume, and dilute with chromatographic hexane to volume. Sample solution:… Read More |
DOFETILIDE | CHEMICAL INFORMATION | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | Change β-[(p-Methanesulfonamidophenethyl)methylamino]methane sulfono-p-phenetidide to: N-{4-[2-(Methyl{2-[4-(methylsulfonamido)phenoxy]ethyl}amino)ethyl]phenyl}methanesulfonamide |
CHLOROPROCAINE HYDROCHLORIDE INJECTION | ASSAY/Procedure | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | In Sample solution: Change Transfer about 100 mg of chloroprocaine hydrochloride to a 100-mL volumetric flask, dissolve in 40 mL of methanol, and dilute with water to volume. to: Transfer a volume of Injection, equivalent to about 100 mg of… Read More |
ORPHENADRINE CITRATE, ASPIRIN, AND CAFFEINE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | Change USP 2-Methylbenzhydrol RS to: USP Methylbenzhydrol RS |
TIOCONAZOLE | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | In USP Tioconazole Related Compound A RS: Change 389.73 to: 389.72 AND In USP Tioconazole Related Compound B RS: Change 458.62 to: 458.60 AND In USP Tioconazole Related Compound C RS: Change C16H13BrCl2… Read More |
ZIPRASIDONE CAPSULES | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Solution B: Change potassium hydroxide to: potassium hydroxide solution AND In Organic Impurities/Analysis: Change 449.40 to: 449.39 |
CEFDINIR | IMPURITIES | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In Organic Impurities/Table 2/footnote a: Change 1N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. to: N-[(Z)-2-(2-Aminothiazol-4-yl)-2-(hydroxyimino)acetyl]glycine. |
ISOSORBIDE MONONITRATE TABLETS | IMPURITIES | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Organic Impurities/Standard solution: Change isosorbide related compound A to: isosorbide mononitrate related compound A AND In System suitability/Suitability requirements/Relative standard… Read More |
MAGNESIUM OXIDE | IMPURITIES/Limit of Calcium | USPNF Online | Online | 25-Feb-2022 | 1-Dec-2022 | NA | NA | In Analysis: Change CU = concentration of Magnesium Hydroxide in the Sample solution (mg/mL) to: CU = concentration of Magnesium Oxide in the Sample solution (mg/mL) |
DOXYCYCLINE HYCLATE TABLETS | ADDITIONAL REQUIREMENTS/USP Reference Standards <11> | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Doxycycline Related Compound A RS: Change 444.43 to: 444.44 AND Change (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide… Read More |
<467> RESIDUAL SOLVENTS | USP REFERENCE STANDARDS <11> | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | Change USP Residual Solvent Class 2—Mixture C RS to: USP Residual Solvents Class 2—Mixture C RS |
ADIPIC ACID | IMPURITIES/Related Substances | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Table 2: Change Pimelic acid 1.21 0.91 Valeric acid 1.21 0.91 to: Pimelic acid 1.21 0.91 Valeric acid 1.46 0.88 |
SOTALOL HYDROCHLORIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | In Analysis: Change Calculate the percentage of any unspecified impurities in the portion of Sotalol Hydrochloride taken: Result = (rU/rS) × (CS/CU) × 100 r… Read More |
DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE CAPSULES | IDENTIFICATION | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | Change A. The UV-Vis spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay. to: A. The UV spectrum of the major peak of the Sample solution… Read More |
CLOMIPHENE CITRATE TABLETS | IMPURITIES/Organic Impurities | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | In Table 2: Change Clomiphene related compound A 0.87 – 2.0 to: Clomiphene related compound A 0.87 1.0 2.0 |
UREA | SPECIFIC TESTS | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Alcohol-Insoluble Matter/Sample solution: Change 100 mg/mL of Urea dissolved in warm alcohol to: Dissolve 5.0 g of Urea in 50 mL of warm alcohol. AND In Alcohol-Insoluble Matter/Analysis: Change If any insoluble… Read More |
LINEZOLID TABLETS | PERFORMANCE TESTS | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | In Dissolution 〈711〉/Test 1/Analysis: Change Result = (rU/rS) × CS × V × (1/L) × 100 rU = peak response of linezolid from the Sample… Read More |
ACYCLOVIR | ASSAY/Procedure | USPNF Online | Online | 29-Apr-2022 | 1-May-2023 | NA | NA | In the Sample solution: Change 0.1 N sodium hydroxide to: 0.01 N sodium hydroxide |
MELENGESTROL ACETATE | CHEMICAL INFORMATION | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | Change 396.52 to: 396.53 |
CALCIUM L-5-METHYLTETRAHYDROFOLATE | IMPURITIES/Related Compounds | USPNF Online | Online | 28-Oct-2022 | 1-Nov-2022 | NA | NA | In Analysis: Change CS = concentration of USP Calcium DL-5-Methyltetrahydrofolate RS in the Standard solution (mg/mL) to: CS = concentration of USP Calcium D,L-5-Methyltetrahydrofolate RS in the … Read More |
LYSINE ACETATE | IMPURITIES/Related Compounds | USPNF Online | Online | 16-Dec-2022 | 1-Jun-2023 | NA | NA | In Chromatographic system/Spray reagent: Change 0.2 g of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) to: 2 mg/mL of ninhydrin in a mixture of butyl alcohol and 2 N acetic acid (95:5) |
THYROID TABLETS | ASSAY/Procedure | USPNF Online | Online | 31-Mar-2023 | 1-Apr-2023 | NA | NA | In Chromatographic system: Change Column: 4.6-cm × 25-cm; packing L1 to: Column: 4.6-mm × 25-cm; packing L1 |
MILBEMYCIN OXIME | CHEMICAL INFORMATION | USPNF Online | Online | 26-May-2023 | 1-Jun-2023 | NA | NA | Change 541.68 Milbemycin B, 5-O-demethyl-28-deoxy-25-methyl-6,28-epoxy-23-hydroxyimino-, [6R,23S,25S(E)]-; (2αE,4E,5′S,6R,6′S,8E,11R,13R,15S,17αR,… Read More |
BLACK CUMIN SEED THYMOQUINONE OIL | SPECIFIC TESTS | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Fats and Fixed Oils 〈401〉, Procedures, Fatty Acid Composition/Table 2: Change Linoleic to: Linoleic acid |
AMOXICILLIN INTRAMAMMARY INFUSION | IDENTIFICATION | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | Change The solution obtained responds to the Identification test under Amoxicillin Capsules. to: Prepare a Standard solution of USP Amoxicillin RS in 0.1 N hydrochloric acid containing 4 mg per mL. Use within 10 minutes after preparation.… Read More |
LIDOCAINE | ASSAY | USPNF Online | Online | 29-Mar-2024 | 1-Apr-2024 | NA | NA | In Procedure: Change Column: 3.9-mm × 30-cm; 4-µm packing L1 to: Column: 3.9-mm × 30-cm; 10-µm packing L1 |
DOXYCYCLINE HYCLATE | IMPURITIES/Organic Impurities | USPNF Online | Online | 27-May-2022 | 1-Jun-2022 | NA | NA | In Table 2, footnote b: Change (4S,4aR,5S,5aR,6R,12aS)-2-Acetyl-4-(dimethylamino)-4a,5a,6,12a-tetrahydro-3,5,10,12,12a-pentahydroxy-6-methyl-tetracene-1,11-dioxo-2-naphthacenecarboxamide. to: (4S,4aR,5S,5a… Read More |
METHSUXIMIDE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | NA | In System suitability/Column efficiency: Change NTL 5800 theoretical plates to: NLT 5800 theoretical plates |
PRIMIDONE TABLETS | ASSAY/Procedure | USPNF Online | Online | 28-Oct-2022 | 1-Dec-2022 | NA | NA | In Sample solution: Change 0.05 mg/mL of primidone from the Standard stock solution in Diluent to: 0.05 mg/mL of primidone from the Sample stock solution in Diluent |
POTASSIUM GLUCONATE ORAL SOLUTION | SPECIFIC TESTS | USPNF Online | Online | 27-Jan-2023 | 1-Feb-2023 | NA | NA | Change Alcohol Determination 〈611〉, Method II—Distillation Method: to: Alcohol Determination 〈611〉, Method I—Distillation Method: |
ROSEMARY | COMPOSITION/Content of Phenolic Diterpenes | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Before injection, pass through a membrane filter of 0.45-µL or finer pore size, to: Before injection, pass through a membrane filter of 0.45-µm or finer pore size, |
METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER | ADDITIONAL REQUIREMENTS/USP Reference Standards 〈11〉 | USPNF Online | Online | 30-Jun-2023 | 1-Jul-2023 | NA | NA | Change USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer, Type C RS) to: USP Methacrylic Acid and Ethyl Acrylate Copolymer (1:1) RS (USP Methacrylic Acid Copolymer Type C RS) |
ZIPRASIDONE HYDROCHLORIDE | IMPURITIES | USPNF Online | Online | 25-Aug-2023 | 1-Sep-2023 | NA | NA | In Organic Impurities/Solution B: Change Acetonitrile, methanol, and Buffer (55:5:40). Adjust with potassium hydroxide TS to a pH of 6.0. to: Acetonitrile, methanol, and Buffer (55:5:40). Adjust with potassium hydroxide solution… Read More |
CEFDINIR | ADDITIONAL REQUIREMENTS | USPNF Online | Online | 17-Nov-2023 | 1-Dec-2023 | NA | NA | In USP Reference Standards 〈11〉/USP Cefdinir Related Compound A RS: Change 413.43 to: 413.42 |
DOXORUBICIN HYDROCHLORIDE | ASSAY | USPNF Online | Online | 26-Apr-2024 | 1-May-2024 | NA | NA | In Procedure/System suitability solution: Add link to USP Store for USP Epirubicin Hydrochloride RS |
<621> CHROMATOGRAPHY | SYSTEM SUITABILITY | USPNF Online | Online | 25-Mar-2022 | 1-Dec-2022 | NA | NA | Change System Repeatability—Assay of an Active Substance or an Excipient to: System Repeatability |
ASCORBIC ACID INJECTION | ASSAY/Procedure | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In Chromatographic system/Column: Change 150-cm × 6-mm; packing L39 to: 15-cm × 6-mm; packing L39 |
METHYLENE BLUE | IMPURITIES/Organic Impurities | USPNF Online | Online | 26-Aug-2022 | 1-Sep-2022 | NA | USPNF 2023 Issue 2 | In footnote a in Table 2: Change 3-(Dimethylamino)-7-(methylamino)-phenothiazine-5-ium chloride. to: 3-(Dimethylamino)-7-(methylamino)phenothiazin-5-ium chloride. |
POTASSIUM CITRATE EXTENDED-RELEASE TABLETS | PERFORMANCE TESTS/Dissolution <711> | USPNF Online | Online | 18-Nov-2022 | 1-Dec-2022 | NA | NA | In Test 6: Change Times: 0.5, 1, and 4 h—for strengths 540 and 1080 mg as potassium citrate monohydrate; 0.5, 1, and 6 h—for strength 1620 mg as potassium citrate monohydrate. to: Times: 0.5, 1, and 4 h—for strength 540 mg as potassium… Read More |
METAPROTERENOL SULFATE TABLETS | Identification/A. | USPNF Online | Online | 24-Feb-2023 | 1-Mar-2023 | NA | NA | Change Proceed as directed in Identification test A under Metaproterenol Sulfate Inhalation Solution, beginning with “Allow the spots to dry”: to: Allow the spots to dry, and develop the chromatogram in a solvent system consisting… Read More |
FLUTICASONE PROPIONATE NASAL SPRAY | OTHER COMPONENTS/Content of Phenylethyl Alcohol | USPNF Online | Online | 28-Apr-2023 | 1-May-2023 | NA | NA | In Sample solution: Change Transfer 1.0 g of the Nasal Spray to a 50-mL volumetric flask. Add about 40 mL of Diluent, and sonicate for 10 min until the supernatant is clear. Use the clear supernatant for analysis. to: Transfer 1.0 g of the… Read More |
POLYVINYL ALCOHOL | IMPURITIES | USPNF Online | Online | 28-Jul-2023 | 1-Aug-2023 | NA | NA | In Limit of Methanol (Methyl Alcohol) and Methyl Acetate/Analysis: Change CU = concentration of methanol (methyl alcohol) or methyl acetate in the Sample solution (mg/mL) to: CU =… Read More |
PANTOPRAZOLE SODIUM DELAYED-RELEASE TABLETS | ASSAY | USPNF Online | Online | 27-Oct-2023 | 1-Nov-2023 | NA | NA | In Procedure/System suitability/Tailing factor: Change NMT 2.0, System suitability solution to: NMT 2.0 for pantoprazole, System suitability solution |
THEOPHYLLINE CAPSULES | IDENTIFICATION | USPNF Online | Online | 26-Jan-2024 | 1-Feb-2024 | NA | NA | Change A: The contents of the Capsules respond to Identification tests A and B under Theophylline Tablets. B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds… Read More |
<621> CHROMATOGRAPHY | ADJUSTMENT OF CHROMATOGRAPHIC CONDITIONS | USPNF Online | Online | 29-Apr-2022 | 1-Dec-2022 | NA | NA | In Liquid Chromatography: Isocratic Elution/Injection volume: Change Result = (Vinj2 = Vinj1 (L2 dc22 )/(L1… Read More |
MELENGESTROL ACETATE | USP Reference standards 〈11〉 | USPNF Online | Online | 24-Jun-2022 | 1-Jul-2022 | NA | NA | In USP Melengestrol Acetate Related Compound A RS: Change 16-Methylene-17α-hydroxy-4-pregnene-3,20-dione 17-acetate. to: 16-Methylene-3,20-dioxopregn-4-en-17-yl acetate. AND In USP Melengestrol Acetate Related Compound B RS: Change 17α-… Read More |